Page last updated: 2024-11-07

spironolactone and Histiocytosis, Langerhans-Cell

spironolactone has been researched along with Histiocytosis, Langerhans-Cell in 1 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Histiocytosis, Langerhans-Cell: A group of disorders resulting from the abnormal proliferation of and tissue infiltration by LANGERHANS CELLS which can be detected by their characteristic Birbeck granules (X bodies), or by monoclonal antibody staining for their surface CD1 ANTIGENS. Langerhans-cell granulomatosis can involve a single organ, or can be a systemic disorder.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andler, W1
Roosen, K1
Reinhardt, V1

Other Studies

1 other study available for spironolactone and Histiocytosis, Langerhans-Cell

ArticleYear
[Hypothalamic hyperosmolarity in childhood (author's transl)].
    Neurochirurgia, 1979, Volume: 22, Issue:2

    Topics: Astrocytoma; Brain Diseases; Brain Neoplasms; Child; Craniopharyngioma; Female; Histiocytosis, Lange

1979